Stebėti
Paloma Giangrande
Paloma Giangrande
Patvirtintas el. paštas uiowa.edu
Pavadinimas
Cituota
Cituota
Metai
Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras
JO McNamara, ER Andrechek, Y Wang, KD Viles, RE Rempel, E Gilboa, ...
Nature biotechnology 24 (8), 1005-1015, 2006
13052006
The E2F1–3 transcription factors are essential for cellular proliferation
L Wu, C Timmers, B Maiti, HI Saavedra, L Sang, GT Chong, F Nuckolls, ...
Nature 414 (6862), 457-462, 2001
7792001
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
JP Dassie, X Liu, GS Thomas, RM Whitaker, KW Thiel, KR Stockdale, ...
Nature biotechnology 27 (9), 839-846, 2009
7212009
Cardiovascular transition at birth: a physiological sequence
SB Hooper, AB Te Pas, J Lang, JJ van Vonderen, CC Roehr, M Kluckow, ...
Pediatric research 77 (5), 608-614, 2015
600*2015
The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding
PH Giangrande, E A. Kimbrel, DP Edwards, DP McDonnell
Molecular and cellular biology 20 (9), 3102-3115, 2000
4502000
The A and B isoforms of the human progesterone receptor: two functionally different transcription factors encoded by a single gene.
PH Giangrande, DP McDonnell
Recent progress in hormone research 54, 291-313; discussion 313, 1999
4271999
E2Fs link the control of G1/S and G2/M transcription
W Zhu, PH Giangrande, JR Nevins
The EMBO journal 23 (23), 4615-4626, 2004
3942004
Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice
JO McNamara, D Kolonias, F Pastor, RS Mittler, L Chen, PH Giangrande, ...
The Journal of clinical investigation 118 (1), 376-386, 2008
3682008
Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay
F Pastor, D Kolonias, PH Giangrande, E Gilboa
Nature 465 (7295), 227-230, 2010
3402010
Myc requires distinct E2F activities to induce S phase and apoptosis
G Leone, R Sears, E Huang, R Rempel, F Nuckolls, CH Park, ...
Molecular cell 8 (1), 105-113, 2001
3352001
Reduction of chromium (VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro
DM Stearns, LJ Kennedy, KD Courtney, PH Giangrande, LS Phieffer, ...
Biochemistry 34 (3), 910-919, 1995
2871995
Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers
KW Thiel, LI Hernandez, JP Dassie, WH Thiel, X Liu, KR Stockdale, ...
Nucleic acids research 40 (13), 6319-6337, 2012
2562012
Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor
PH Giangrande, G Pollio, DP McDonnell
Journal of Biological Chemistry 272 (52), 32889-32900, 1997
2451997
Therapeutic applications of DNA and RNA aptamers
KW Thiel, PH Giangrande
Oligonucleotides 19 (3), 209-222, 2009
2132009
Hormone-Dependent Interaction between the Amino- and Carboxyl-Terminal Domains of Progesterone Receptor in Vitro and in Vivo
MJ Tetel, PH Giangrande, SA Leonhardt, DP McDonnell, DP Edwards
Molecular endocrinology 13 (6), 910-924, 1999
2061999
Multifunctional aptamer-miRNA conjugates for targeted cancer therapy
CL Esposito, L Cerchia, S Catuogno, G De Vita, JP Dassie, G Santamaria, ...
Molecular therapy 22 (6), 1151-1163, 2014
1862014
Rational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modeling
WM Rockey, FJ Hernandez, SY Huang, S Cao, CA Howell, GS Thomas, ...
Nucleic acid therapeutics 21 (5), 299-314, 2011
1582011
Rapid identification of cell-specific, internalizing RNA aptamers with bioinformatics analyses of a cell-based aptamer selection
WH Thiel, T Bair, AS Peek, X Liu, J Dassie, KR Stockdale, MA Behlke, ...
Public Library of Science 7 (9), e43836, 2012
1462012
A role for E2F6 in distinguishing G1/S-and G2/M-specific transcription
PH Giangrande, W Zhu, S Schlisio, X Sun, S Mori, S Gaubatz, JR Nevins
Genes & development 18 (23), 2941-2951, 2004
1412004
Isolation and optimization of murine IL-10 receptor blocking oligonucleotide aptamers using high-throughput sequencing
A Berezhnoy, CA Stewart, JO Mcnamara II, W Thiel, P Giangrande, ...
Molecular Therapy 20 (6), 1242-1250, 2012
1382012
Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.
Straipsniai 1–20